Publicaciones (34) Publicaciones de FERNANDO MARTÍNEZ SAGASTI

2024

  1. Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients

    International Journal of Antimicrobial Agents

  2. The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial

    Journal of Critical Care, Vol. 79

2023

  1. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

    The Lancet Respiratory Medicine, Vol. 11, Núm. 10, pp. 894-904

2022

  1. Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study

    Open Forum Infectious Diseases, Vol. 9, Núm. 4

  2. Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients

    International Journal of Antimicrobial Agents, Vol. 59, Núm. 3

  3. Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis

    Intensive Care Medicine, Vol. 48, Núm. 11, pp. 1593-1606

  4. Urgent need for a rapid microbiological diagnosis in critically ill pneumonia

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, pp. 6-14

2021

  1. Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients

    International Journal of Antimicrobial Agents, Vol. 57, Núm. 3

  2. Post mortem core needle biopsy of Covid-19 fatalities

    Revista Espanola de Patologia, Vol. 54, Núm. 3, pp. 165-168

2019

  1. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project

    Intensive Care Medicine, Vol. 45, Núm. 12, pp. 1703-1717

2018

  1. False image of intracarotideal air after a suicide attempt

    Journal of Clinical Ultrasound, Vol. 46, Núm. 9, pp. 614-616

  2. Preliminary experience on the safety and tolerability of mechanical “insufflation-exsufflation” in subjects with artificial airway

    Intensive Care Medicine Experimental , Vol. 6, Núm. 1

  3. Usefulness of biomarkers on infection management: with or without them?

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 31, pp. 43-46

2016

  1. Monotherapy vs. combined therapy in the treatment of multi-drug resistance gramnegative bacteria

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 29, pp. 43-46

  2. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry

    Annals of Intensive Care, Vol. 6, Núm. 1

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2013

  1. Hemoperfusión directa con el cartucho de polimixina b fijada en la sepsis grave secundaria a perforación intestinal: Hallazgos hemodinámicos y consideraciones clínicas con respecto a la anticoagulación

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 2, pp. 151-158

2012

  1. Enteral antimicrobials

    Infection Control in the Intensive Care Unit (Springer-Verlag Italia s.r.l.), pp. 123-142

2011

  1. La glucemia de las primeras 24 horas no es un factor pronóstico de mortalidad en pacientes críticos

    Nutricion Hospitalaria, Vol. 26, Núm. 3, pp. 622-635

2010

  1. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit

    JAMA - Journal of the American Medical Association, Vol. 303, Núm. 22, pp. 2260-2264